Mayo Clinic Release: Trio of Studies Support Use of PET/CT Scans as Prostate Cancer Staging Tool

ROCHESTER, Minn.--(BUSINESS WIRE)--Recent studies have suggested that C-11 choline positron emission tomography/computerized tomography (PET/CT) scans can be utilized as a staging and potentially therapeutic tool in prostate cancer. The results of three studies, released today during a meeting of the North Central Section of the American Urological Association (http://www.ncsaua.org/default.aspx), validate findings in Europe and expand the potential use of C-11 choline PET scans.

MORE ON THIS TOPIC